The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...

A drug that can slow the progression of Alzheimer's disease has been blocked for use on the NHS due to cost concerns.

The U.K. watchdog declines to endorse Eli Lilly's Alzheimer's drug donanemab, citing lack of value for the NHS and ...

A new Alzheimer’s drug has been rejected by the health spending watchdog for general use within NHS England, with the ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved US pharma major Eli Lilly’s Kisunla (donanemab ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...